GHSI Stock Overview
A clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Guardion Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.11 |
| 52 Week High | US$10.75 |
| 52 Week Low | US$5.01 |
| Beta | 0.92 |
| 11 Month Change | -8.93% |
| 3 Month Change | 7.01% |
| 1 Year Change | 21.42% |
| 33 Year Change | -83.88% |
| 5 Year Change | -88.17% |
| Change since IPO | -99.18% |
Recent News & Updates
Recent updates
Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost
Jun 06
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Apr 10Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward
Feb 06Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues
Apr 17Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M
Aug 11Guardion Health closes Activ Nutritional acquisition
Jun 02Guardion Health initiates GlaucoCetin glaucoma trial
May 03The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More
Jan 15Guardion Health names industry veteran Bret Scholtes as new president and CEO
Dec 28Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?
Nov 24
Shareholder Returns
| GHSI | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -2.7% | 0.5% | 4.0% |
| 1Y | 21.4% | -19.1% | 24.9% |
Return vs Industry: GHSI exceeded the US Personal Products industry which returned -22.5% over the past year.
Return vs Market: GHSI matched the US Market which returned 21.7% over the past year.
Price Volatility
| GHSI volatility | |
|---|---|
| GHSI Average Weekly Movement | 6.8% |
| Personal Products Industry Average Movement | 9.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: GHSI has not had significant price volatility in the past 3 months.
Volatility Over Time: GHSI's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 9 | Jan Hall | www.guardionhealth.com |
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement.
Guardion Health Sciences, Inc. Fundamentals Summary
| GHSI fundamental statistics | |
|---|---|
| Market cap | US$11.87m |
| Earnings (TTM) | -US$5.93m |
| Revenue (TTM) | US$6.43m |
1.8x
P/S Ratio-2.0x
P/E RatioIs GHSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GHSI income statement (TTM) | |
|---|---|
| Revenue | US$6.43m |
| Cost of Revenue | US$3.54m |
| Gross Profit | US$2.88m |
| Other Expenses | US$8.81m |
| Earnings | -US$5.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.62 |
| Gross Margin | 44.86% |
| Net Profit Margin | -92.26% |
| Debt/Equity Ratio | 0% |
How did GHSI perform over the long term?
See historical performance and comparison